During the past decade, Indianapolis Gastroenterology Research Foundation conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 14 clinical trials were completed, i.e. on average, 127.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 9 clinical trials were completed. i.e. 900% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indianapolis Gastroenterology Research Foundation" #1 sponsor was "Gilead Sciences" with 16 trials, followed by "Target PharmaSolutions, Inc." with 2 trials sponsored, "Abbott" with 1 trials sponsored, "Bausch Health Americas, Inc." with 1 trials sponsored and "Biogen" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indianapolis Gastroenterology Research Foundation" #1 collaborator was "COUR Pharmaceuticals Development Company, Inc." with 1 trials as a collaborator, "Elan Pharmaceuticals" with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Indianapolis Gastroenterology Research Foundation" are "Chronic Hepatitis C" (5 trials), "Nonalcoholic Steatohepatitis" (5 trials), "Crohn's Disease" (3 trials), "Hepatitis C, Chronic" (3 trials) and "Irritable Bowel Syndrome" (2 trials). Many other conditions were trialed in "Indianapolis Gastroenterology Research Foundation" in a lesser frequency.

Most popular intervention types in "Indianapolis Gastroenterology Research Foundation" are "Drug" (19 trials), "Biological" (3 trials), "Device" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "RBV" (6 trials), "PEG" (3 trials), "SEL" (3 trials) and "SOF" (3 trials). Other intervention names were less common.

The vast majority of trials in "Indianapolis Gastroenterology Research Foundation" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Indianapolis Gastroenterology Research Foundation". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Indianapolis Gastroenterology Research Foundation, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Indianapolis Gastroenterology Research Foundation, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".